FiercePharma6h
Sanofi's RSV antibody Beyfortus, after smashing blockbuster sales threshold, still has room to grow in US: execs
While Sanofi’s immunology megablockbuster Dupixent predictably dominated the company’s sales charts in 2024, a new golden ...
You’re not imagining it. The ‘quad-demic’ is making everyone sick.
Respiratory Syncytial Virus, or RSV, is a common respiratory virus that causes mild, cold-like symptoms in most people, ...
More than 85,000 infants and toddlers diagnosed with RSV in 2024 ahead of national vaccine rollout
More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.
Has a ‘quademic’ hit the US? 4 viral infections and what to know about them
Four viruses are circulating in the U.S., sparking concerns of a possible “quademic." Here's what to know about risk factors ...
Cyprus Mail on MSN12h
Doctors urge RSV vaccine as Cyprus’ hospitals fill up
The Cyprus pulmonology society on Thursday urged Health Minister Michael Damianos to approve a respiratory syncytial virus (RSV) vaccine for use Cyprus. The society also seeks its inclusion into the ...
Managed Healthcare Executive8d
A Look at Human Metapneumovirus — a Respiratory Virus You've Likely Had Without Knowing
Human Metapneumovirus (HMPV) is a respiratory virus that may not be on most folk’s radars, but it’s more common than you ...
Newslaundry7d
HMPV is a silent threat to respiratory health
HMPV mainly affects the respiratory system and can cause a wide range of illnesses, from mild cold-like symptoms to severe ...
pulmonologyadvisor8d
Dyspnea Is a Leading Symptomatic Indicator for Severe RSV Outcomes
Alone and in combination with other lower respiratory tract disease signs and symptoms, dyspnea is the best predictor of severe RSV outcomes.
Tucson Local Media1d
Winter has witnessed a ‘quad-emic’
Norovirus is commonly known as the stomach flu. This virus was discovered in 1972 during research into an outbreak of ...
The lesser-known winter virus that is different to flu and Covid but just as dangerous
Human metapneumovirus (hMPV) has been hitting the headlines recently as one of the lesser-known winter illnesses that can ...
ENA Respiratory Publishes Review of Development of Novel Intranasal Antiviral Host Defense Immune Enhancer INNA-051 in Antiviral Research
ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defense immune enhancers to minimize the impact of respiratory viral infections in at-risk populations, announces ...